Lecture 32 - Drugs Acting Through Receptors 2 Flashcards

(30 cards)

1
Q

What is potency?

A

Affinity

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Do drugs with different potencies reach the same maximum?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between a weak agonist and a full agonist?

A

Different efficacies:
Weak: little response in the cell
Full: full response in the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is potency?

A

The amount of drug required to elicit a certain response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Draw a dose-response curve of two drugs with different potencies

A

:)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Will a weak agonist ever reach the maximum?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Will partial agonists ever reach the maximum?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is intrinsic efficacy?

A

This is the ability of the ligand to elicit a response in the cell

It is a property of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is coupling in pharmacology?

A

Transduction

This is the relationship between the binding of the ligand to the receptor and the transduction pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The greater the coupling, …

A

the greater the intrinsic efficacy of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Draw a stimulus-response curve for two drugs of different coupling efficiency

A

Lecture 31

Slide 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Draw a concentration-response curve:

  • one drug
  • different numbers of receptors
A

Lecture 31

Slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the ‘gold-standard’ B-adrenoceptor agonist?

A

Isoprenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the features of isoprenaline?

A

High intrinsic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Compare isoprenaline with prenalterol

A

Isoprenaline: high intrinsic efficacy
Prenalterol: modest instrinsic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe an instance of tissue-dependency of the agonist

A

Prenalterol

Has much less of a response in the gut than in the atria due to the receptor density

17
Q

Describe an instance of disease-dependence of an agonist’s activity

A

Prenalterol

TIssue has been desensitised to Prenalterol.
Has much less of a response in failing heart than in healthy heart, due to receptor number

Isoprenaline is also less potent in the failing heart

18
Q

What are the drug-dependent factors of potency?

A

I/ Affinity

II/ Efficacy

19
Q

What are the tissue-dependent factors of potency?

A

I/ Number of receptors

II/ Coupling

20
Q

What are the different types of antagonism?

A

I/ Chemical

II/ Functional
Mechanical

21
Q

Describe an example of chemical antagonism

A

Protamine binds to heparin, neutralising it

22
Q

What type of molecule is protamine?

23
Q

What is competitive antagonism?

A

This is when a molecule binds to the active site of a receptor, preventing a response

24
Q

What is surmountable antagonism?

A

The antagonism can be overcome by adding more of the agonist

Concontration dependent antagonism

25
Describe the two sites that the agonist and antagonist act on in competitive antagonism
They act on the same site
26
Draw a concentration-response graph of a drug at a certain concentration when there is an antagonist present, and when there is no antagonist
Slide 28
27
Draw a dose-response curve of a drug when there is and isn't an antagonist present
Slide 29
28
Is the maximum still reached in competitive antagonism?
Yes - if the concentration of the agonist is high enough
29
What is happening in non-competitive inhibition?
The antagonist is binding to an allosteric site, leading to a change in the shape of the active site
30
What is the reason for the difference between partial and full agonists?
Different functional groups